Thomas Wirth
- Cancer Research top 0.5%
- NF-κB Signaling Pathways 42
- Immunology top 0.5%
- Immune Response and Inflammation 22
- Immune Cell Function and Interaction 16
- T-cell and B-cell Immunology 14
- Oncology top 1%
- Cytokine Signaling Pathways and Interactions 7
- Neurology top 1%
- Neuroinflammation and Neurodegeneration Mechanisms 8
- Molecular Biology top 1%
- FOXO transcription factor regulation 13
-
- Lymphoma Diagnosis and Treatment 13
- Co-authors
- Bernd BaumannHartmut BeugMargit A. HuberNorbert KrautNinel AzoiteiHubert PehambergerAndreas SommerStefan Grünert
- Cited by
- Cancer ResearchImmunologyOncology
- Partner nations
- GermanyUnited StatesChina
In The Last Decade
Thomas Wirth
120 papers receiving 8.4k citations
Hit Papers
Peers
Comparison fields: 5 of 123
- Cancer Research 2.6k
- Immunology 2.5k
- Oncology 2.1k
- Neurology 550
- Molecular Biology 4.1k
Countries citing papers authored by Thomas Wirth
This map shows the geographic impact of Thomas Wirth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Wirth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Wirth more than expected).
Fields of papers citing papers by Thomas Wirth
This network shows the impact of papers produced by Thomas Wirth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Wirth. The network helps show where Thomas Wirth may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Thomas Wirth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2023 | 11 | |
| 4 | 2022 | 9 | |
| 5 | 2021 | 4 | |
| 6 | 2020 | 81 | |
| 7 | 2020 | 24 | |
| 8 | 2017 | 28 | |
| 9 | 2017 | 24 | |
| 10 | 2016 | 7 | |
| 11 | 2013 | 21 | |
| 12 | 2012 | 7 | |
| 13 | 2010 | 180 | |
| 14 | 2006 | 36 | |
| 15 | 2005 | 16 | |
| 16 | NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progressionbreakdown → | 2004 | 734 |
| 17 | 2004 | 60 | |
| 18 | 2002 | 73 | |
| 19 | NF-κB is activated and promotes cell death in focal cerebral ischemiabreakdown → | 1999 | 570 |
| 20 | 1996 | 8 |
About Thomas Wirth
Thomas Wirth is a scholar working on Cancer Research, Immunology and Aging, having authored 122 papers that have together received 8.5k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (42 papers), Immune Response and Inflammation (22 papers), Immune Cell Function and Interaction (16 papers), T-cell and B-cell Immunology (14 papers), Lymphoma Diagnosis and Treatment (13 papers), FOXO transcription factor regulation (13 papers), Neuroinflammation and Neurodegeneration Mechanisms (8 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Cancer Research (2.6k citations), Immunology (2.5k citations) and Oncology (2.1k citations). Thomas Wirth has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Bernd Baumann, Hartmut Beug, Margit A. Huber, Norbert Kraut, Ninel Azoitei, Hubert Pehamberger, Andreas Sommer, Stefan Grünert, Alexey Ushmorov and Harald J. Maier. Their work appears in journals such as Blood, Journal of Biological Chemistry, Cancers, European Journal of Immunology and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.